Prof Katharine Barnard is a Visiting Professor and internationally renowned expert who specializes in the psychosocial impact and management of illness and long-term conditions. She led the only team ever to be awarded FDA MDDT qualification for a patient-reported outcome measure in diabetes (INSPIRE). Katharine is an Expert Advisor to NICE, to Government and to the FDA. Katharine Chairs a global team of experts in writing a consensus statement on the standardization of patient-reported outcomes. This document will provide a blueprint for how PROs are understood and assessed in the context of mental health safety by regulatory bodies, government research funding bodies and other key stakeholder groups worldwide. She also Chairs the FDA RESCUE Global Collaborative Community to reduce incidents of self-injury and suicide by people with diabetes. Katharine developed the underpinning theoretical model and science behind Spotlight-AQ; a concrete exemplar of biopsychosocial healthcare delivery within the constraints of existing healthcare systems and structures. She is the Chief Science Officer and founder. Katharine’s goal is to minimize the burden of diabetes and improve the quality of life for people living with it. Furthermore, to reduce the burden on healthcare professionals providing crucial support.